The Globe and Mail reports in its Thursday, March 7, edition that Neighbourly Pharmacy shareholders are set to vote Friday on a plan to sell their stock to Montreal-based Persistence Capital Partners, which already owns half the company. The Globe's David Milstead writes that the offer of $18.50 per share, plus a sliver of future profits, is 52.6 per cent above where Neighbourly shares traded before its offer became known, the company's board highlights in the deal prospectus sent to stockholders. It is, however, less than half of Neighbourly's peak share price of more than $40, set a little over two years ago, and barely more than its May, 2021, initial public offering price. Mr. Milstead says the offering price is less than Neighbourly is likely currently worth -- if you question a conveniently timed pessimistic forecast from management. In September, TD told Neighbourly it was worth $20.50 to $25.50 per share, neatly capturing the Persistence Capital offer at the low end. On Oct. 3, the company announced a deal at $20.50. On Dec. 17, after Neighbourly had cut its guidance, Persistance lowered its bid to $18.50. Veritas analyst Kathleen Wong says, "The minority shareholders basically got screwed."